Sotera Health Company (SHC)

Market Cap	3.94B +11.4%
Revenue (ttm)	1.16B +5.7%
Net Income	77.95M +75.6%
EPS	0.27 +72.2%
Shares Out	284.39M
PE Ratio	51.30
Forward PE	14.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,230,673
Open	13.74
Previous Close	13.57
Day's Range	13.67 - 13.96
52-Week Range	9.53 - 19.85
Beta	1.87
Analysts	Buy
Price Target	20.67 (+49.24%)
Earnings Date	Apr 30, 2026

About SHC

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion seg...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 20, 2020
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: SHC
• Website: https://soterahealth.com

Financial Performance

In 2025, Sotera Health Company's revenue was $1.16 billion, an increase of 5.74% compared to the previous year's $1.10 billion. Earnings were $77.95 million, an increase of 75.79%.

Analyst Summary

According to 7 analysts, the average rating for SHC stock is "Buy." The 12-month stock price target is $20.67, which is an increase of 49.24% from the latest price.

Price Target

$20.67

(49.24% upside)

Analyst Consensus: Buy